TCIM
NMTR

TIAA CREF Investment Management’s 9 Meters Biopharma NMTR Stock Holding History

TIAA CREF Investment Management’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$54K Buy
1,401
+105
+8% +$4.54K ﹤0.01% 2991
2018
Q4 		$60K Hold
1,296
– – ﹤0.01% 2989
2018
Q3 		$177K Sell
1,296
-1,223
-49% -$210K ﹤0.01% 3004
2018
Q2 		$1.19M Buy
+2,519
New +$927K ﹤0.01% 2422

Other funds holding NMTR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

TIAA CREF Investment Management's NMTR Position: Q1 2019 in Review

TIAA CREF Investment Management increased its 9 Meters Biopharma (NMTR) stake by 8.1% in Q1 2019, buying an estimated $4.54K and bringing the position to 1,401 shares worth $54K. The position accounts for ﹤0.01% of the portfolio, ranked #2991.

TIAA CREF Investment Management first reported a position in NMTR in Q2 2018 and has held it in 4 quarters since. The position peaked at $1.19M in Q2 2018. 38 funds tracked by Wall St. Rank hold NMTR as of Q1 2019.

  • TIAA CREF Investment Management held 1,401 shares of 9 Meters Biopharma worth $54K as of Q1 2019.
  • TIAA CREF Investment Management bought 105 9 Meters Biopharma shares in Q1 2019, an estimated $4.54K.
  • 9 Meters Biopharma made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2991 holding.
  • TIAA CREF Investment Management first reported a position in 9 Meters Biopharma in Q2 2018 and has held it in 4 quarters since.
  • TIAA CREF Investment Management's 9 Meters Biopharma position peaked at $1.19M in Q2 2018.
  • 38 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.